CJC-1134-PC Injection

· Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CJC-1134-PC Injection, covering 2025-07-10 to 2025-07-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CJC-1134-PC Injection in Antidiabetic Treatment-naive Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control [Phase 3]

See pricing